NCT03977415

Interstitial Lung Disease in Early Rheumatoid Arthritis

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 76 (estimated)
• Sponsor: National Jewish Health · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine how interstitial lung disease can be predicted over time in early rheumatoid arthritis. The investigators will study blood and phlegm samples from participants, along with quality of life questionnaires to determine if and how the presence of ILD may impact the participants quality of life over time.

Detailed description

Participation involves 5 study visits over an 18 month timeframe. During each of these visits, a recent medical history and physical exam will take place, blood and phlegm will be collected, quality of life questionnaires will be administered, and a CT-scan of the chest and pulmonary function testing may be performed.

Conditions

• Rheumatoid Arthritis
• Interstitial Lung Disease

Timeline

• Start date: 2018-03-27
• Primary completion: 2020-02-01
• Completion: 2021-08-01
• First posted: 2019-06-06
• Last updated: 2019-06-06

Locations

1 site across 1 country: United States